(19)
(11) EP 1 482 946 A1

(12)

(43) Date of publication:
08.12.2004 Bulletin 2004/50

(21) Application number: 02707980.5

(22) Date of filing: 14.03.2002
(51) International Patent Classification (IPC)7A61K 31/565, A61K 31/57
(86) International application number:
PCT/US2002/007562
(87) International publication number:
WO 2003/077923 (25.09.2003 Gazette 2003/39)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(71) Applicant: Watson Pharmaceuticals, Inc.
Corona, CA 92880 (US)

(72) Inventor:
  • TAN, Domingo, Y.
    Irvine, CA 92620 (US)

(74) Representative: Thomson, Paul Anthony 
Potts, Kerr & Co.15, Hamilton Square
BirkenheadMerseyside CH41 6BR
BirkenheadMerseyside CH41 6BR (GB)

   


(54) PROGESTERONE ORAL DRUG DELIVERY SYSTEM